Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Quizartinib for Acute Myeloid Leukemia
Recruiting1 awardPhase 1 & 2
Montréal, Quebec
This trial is for an experimental drug and is only for children or young adults with FLT3-ITD AML that has come back or is not responding to treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service